Recently, the role of GR activation in epithelial tumor cells and the tumor microenvironment has become increasingly appreciated, in part due to the understanding that GR activity has differential effects depending upon cancer subtype [2,3]. This evidence concerns the gene NR3C1 and neoplasm.